DailyDoctor Archive Specialties Get app
Back to the 28 September 2026 edition

Research · 03 of 06

Esketamine lowered pulmonary complications on day 1 after lung resection, but not beyond

Esketamine's day-1 reduction in pulmonary complications after lung resection did not last or change recovery; it is not a reason to add it.

Design
Randomised, double-blind controlled trial
Population
80 adults having thoracoscopic radical lung cancer surgery
Primary outcome
Postoperative pulmonary complications on day 1
Effect
37.5% vs 72.5% (P 0.002); no difference on days 3 and 7 or in secondary outcomes

This double-blind trial randomised 80 adults having thoracoscopic radical lung cancer surgery to perioperative esketamine or control, on the hypothesis that its anti-inflammatory effects protect the lung.

Postoperative pulmonary complications on day 1 were lower with esketamine (37.5% vs 72.5%, P 0.002). But there was no difference on days 3 or 7, in severity, nausea and vomiting, pain, drain duration, length of stay, unplanned ICU admission or mortality.

A day-1 difference that vanishes by day 3 and changes nothing downstream is not a reason to add esketamine for lung protection. The trial is small and single-centre, and the very high control-group rate (72.5%) suggests a broad complication definition.

  • Do not add esketamine to thoracic anaesthesia for lung protection on this evidence.
  • Keep to established lung-protective ventilation, good analgesia and early mobilisation after lung resection.
  • Note that esketamine's availability in India for this use is not established.
  • Look at how a trial defines pulmonary complications before comparing rates across studies.

Why it matters

It shows how an early, significant primary outcome can mislead when nothing that matters to patients changes afterwards.

Don't overread it

Eighty patients, one centre, and a benefit confined to day 1 with no effect on any later outcome.

The statistics, in plain English

The difference on day 1 is large and statistically significant, but a result confined to the first day, with no effect on length of stay or ICU admission, is unlikely to be clinically significant.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

obstetricanaesacutepainregionalanaesperioperativegeneralanaes

Tomorrow morning, before your first patient

One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app